0.8038
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Best deals to access real time data! |
CHART Trader
Monthly Subscription
for only
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Brooklyn ImmunoTherapeutics Inc | BTX | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded
![]() |
|
---|---|---|---|---|
0.00 | 0.0% | 0.8038 | 20:00:00 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.8038 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 0.70 - 10.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 0.8038 | USD |
Brooklyn ImmunoTherapeutics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 46.18M | 57.45M | 51.55M | $ - | $ - | -2.58 | -0.30 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | 2.05M | 10.70% |
Brooklyn ImmunoTherapeut... News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.8852 | 0.9439 | 0.70 | 0.7790807 | 797,940 | -0.0814 | -9.2% |
1 Month | 1.46 | 1.4688 | 0.70 | 0.9846874 | 538,817 | -0.6562 | -44.95% |
3 Months | 2.20 | 2.38 | 0.70 | 1.56 | 452,320 | -1.40 | -63.46% |
6 Months | 7.71 | 7.95 | 0.70 | 3.15 | 474,670 | -6.91 | -89.57% |
1 Year | 9.86 | 10.00 | 0.70 | 3.57 | 481,324 | -9.06 | -91.85% |
3 Years | 9.86 | 10.00 | 0.70 | 3.57 | 481,324 | -9.06 | -91.85% |
5 Years | 9.86 | 10.00 | 0.70 | 3.57 | 481,324 | -9.06 | -91.85% |
Brooklyn ImmunoTherapeut... Description
Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. |